“…Nevertheless, it has been shown that a Myc mutant lacking MB2 still efficiently activates the expression of some target genes and artificial reporters (Kato et al, 1990;BelloFernandez et al, 1993;Li et al, 1994;Brough et al, 1995;Lee et al, 1997;Xiao et al, 1998;Nikiforov et al, 2002), although many targets are only poorly activated by such a protein (Conzen et al, 2000;Hirst and Grandori, 2000;Bouchard et al, 2001;Nikiforov et al, 2002;Kenney et al, 2003;Cowling and Cole, 2007). Such a MycΔMB2 mutant also fails to repress the genes that are normally down-regulated by wild type Myc (Li et al, 1994;Lee et al, 1997), including the c-myc locus itself (Penn et al, 1990;Bush et al, 1998;Oster et al, 2003). Importantly, the biological function of the MB2 cannot be replaced by the strong transactivation domain of the viral transcription factor VP16 (Brough et al, 1995).…”